![Engineering biopharmaceutical formulations to improve diabetes management | Science Translational Medicine Engineering biopharmaceutical formulations to improve diabetes management | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abd6726/asset/1d91d4dc-8e38-4ac7-9146-67da340020c3/assets/graphic/abd6726-f1.jpeg)
Engineering biopharmaceutical formulations to improve diabetes management | Science Translational Medicine
![The promising future of insulin therapy in diabetes mellitus | American Journal of Physiology-Endocrinology and Metabolism The promising future of insulin therapy in diabetes mellitus | American Journal of Physiology-Endocrinology and Metabolism](https://journals.physiology.org/cms/10.1152/ajpendo.00608.2020/asset/images/medium/e-00608-2020r01.png)
The promising future of insulin therapy in diabetes mellitus | American Journal of Physiology-Endocrinology and Metabolism
![A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2022.0167/asset/images/medium/dia.2022.0167_figure2.jpg)
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics
![A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2022.0167/asset/images/medium/dia.2022.0167_figure1.jpg)
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics
![A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2022.0167/asset/images/medium/dia.2022.0167_figure4.jpg)
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics
![The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes | Diabetes Technology & The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes | Diabetes Technology &](https://www.liebertpub.com/cms/10.1089/dia.2022.0341/asset/images/medium/dia.2022.0341_figure1.jpg)
The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes | Diabetes Technology &
![A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2022.0167/asset/images/medium/dia.2022.0167_figure3.jpg)